PRISM Stock IndexesCurrent Value% Change (Daily)% Change (Inception)Most ActiveTop % GainersTop % Losers
Cannabis$49.00-5.5%-51.0%SNDL 100,953 %CGC -8.285%
EV$63.90-4.8%-36.1%NKLA 13,243SPAQ 5.556%FSR -12.795%
Gene Therapy$48.80-3.1%-51.2%DRNA 3,032ORGS 11.905%SGMO -11.471%
MedDevices$178.20-3.5%78.2%ATRS 4,882CRY 1.418%CUTR -19.379%
MedDiagnostics$100.10-2.9%0.1%OPK 4,323THMO 6.423%OSUR -19.031%
Solar$79.50-2.7%-20.5%HYSR 7,166CSIQ 5.079%MAXN -8.978%
Uranium$87.40-3.3%-12.6%UEC 16,561NXE 0.873%BKUCF -8.75%
Vaccines & Cell Therapy$188.80-4.5%88.8%SRNE 9,563DYAI 10.329%SIGA -15.512%
Web 3.0$44.00-6%-56.0%MARA 11,296SNII 3.33%HIVE -10.118%

Prism Daily

PRISM Solar Index is the Index to Watch as Europe Plans “Massive” Increase in Green Energy

The PRISM Solar Index is the only index up today, largely due to the EU's new plan to dramatically increase green energy output, which is great news for solar companies. All new buildings in the EU would be fitted with…

IonQ (IONQ) Jumps on Announcement of IonQ Forte – Its Latest Generation of Quantum Systems

IonQ (IONQ) received a surge of around 17.5% upon their announcement of its latest generation of quantum systems. The new system, IonQ Forte, features novel, cutting-edge optics technology that enables increased accuracy and further enhances IonQ's system performance. Forte is…

Inovio Pharmaceuticals (INO) Down Almost 33% For the Week

Inovio Pharmaceuticals (INO) tumbled almost 33% over the past week. The investor sell-off is largely in part due to the Company's shift in focus from a Covid-19 vaccine to a Covid-19 booster. This also comes on the heels of their…

CEO3in60 VIDEOS

CEO3in60 Logo

Learn About Tomorrow’s Leading Companies Straight From The Source

The modern investor needs trusted, relevant information, delivered quickly and concisely. CEO3in60 provides a platform for management to succinctly share their company’s value proposition in their own words. We take the CEOs of the most dynamic up and coming companies and put them in front of the camera to provide you with the top three reasons why you should be paying attention to their business, all in less than sixty seconds.

Asensus Surgical

Asensus Surgical (NYSE American: ASXC) is leading the digital surgical market with Performance-Guided Surgery™, which enhances the work of surgeons using state-of-the-art robotics, augmented intelligence and machine learning. Shameze Rampertab, Chief Financial Officer at Asensus, outlines three value drivers for investors that will have the market paying attention in the coming months.

Soligenix

Soligenix (NASDAQ: SNGX) is developing and commercializing products to treat rare diseases in oncology and dermatology where there is an unmet medical need. Chris Schaber, President and CEO of Soligenix, Inc. spends one minute outlining three value drivers that will have investors

Read more about Soligenix, Inc.

Traders Lens

“June Crude Oil is on the verge of breaking a neckline on an inverse head and shoulders pattern – If for holds, a close above $111.40 looks like a rally toward new highs near $125”

“June Crude Oil is on the verge of breaking a neckline on an inverse head and shoulders pattern –
If for holds, a close above $111.40 looks like a rally toward new highs near $125″

[More Traders Lens]

Prism View

Why Soligenix Shares Jumped 10% Yesterday

After the news that it received a U.S. patent allowance for its vaccine platform, Soligenix (Nasdaq:SNGX) shares recorded a double-digit jump of 10% yesterday. The late-stage biopharma focused on developing and commercializing products to treat rare diseases reported that the U.S.…

Quoin Pharmaceuticals (NASDAQ:QNRX) Signs Second Exclusive Research Agreement with Australian University

Advancing scientific research into developing treatments for rare and orphan diseases, Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) signed a second exclusive research agreement with the Queensland University of Technology (QUT) in Australia. The new agreement centers on a potential treatment for…

Anixa Biosciences (ANIX) Jumps Almost 20% Despite Overall Market Losses

Despite a rough day in the market overall, Anixa Biosciences (ANIX) managed to leap almost 20% for the day. The Company announced a presentation outlining the design of its breast cancer vaccine trial at the American Society of Clinical Oncology…

PAVmed Inc (PAVM) Jumps 16.5%

On an overall negative day for the PRISM Stock Indexes, PAVmed stood out with a very…

Why Quoin Stock Jumped 40% Yesterday

Quoin (Nasdaq:QNRX), a boutique biotech developing and commercializing treatments for rare skin diseases, shared the notable…

LogicBio Therapeutics (LOGC) Among Worst Performing On the Nasdaq

LogicBio Therapeutics (LOGC) fell almost 26% for the day, which was among the worst losses on…

NVAX Climbs Almost 8% For the Day

Novavax (NVAX) rose around 8% on the news of a new study; a Covid-19 booster study…